CN110464821A - Draft conserves cream - Google Patents

Draft conserves cream Download PDF

Info

Publication number
CN110464821A
CN110464821A CN201810431806.4A CN201810431806A CN110464821A CN 110464821 A CN110464821 A CN 110464821A CN 201810431806 A CN201810431806 A CN 201810431806A CN 110464821 A CN110464821 A CN 110464821A
Authority
CN
China
Prior art keywords
extract
oil
cream
ostrich
draft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810431806.4A
Other languages
Chinese (zh)
Inventor
王亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810431806.4A priority Critical patent/CN110464821A/en
Publication of CN110464821A publication Critical patent/CN110464821A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/583—Snakes; Lizards, e.g. chameleons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of draft to conserve cream, comprising: water 56.04%, white oil 7%, stearic acid 6%, camphor 6%, vaseline 4.5%, wintergreen 4.5%, glycerin monostearate 3.5%, stearyl alcohol 3.5%, glycerol 1.8%, menthol 1%, triethanolamine 0.7%, Salvia root P.E 0.7%, ginger oil 0.7%, pallas pit viper extract 0.5%, Herba speranskiae tuberculatae extract 0.5%, safflower extract 0.5%, extractive of pubescent angelica root coumarin 0.5%, Millettia extract 0.5%, bee venom 0.5%, ostrich oil 0.35%, imidazolidinyl urea 0.4% and chlorhexidine acetate 0.31%.Present invention combination doctor trained in Western medicine safety is good, effect active material outstanding, obtains by largely testing, has effects that dispelling wind and eliminating dampness, relaxing tendons and activating collaterals, promoting blood circulation and stopping pain, solution poison rash.

Description

Draft conserves cream
Technical field
The present invention relates to cosmetic technical field, more particularly to draft conserves cream.
Background technique
Neck-shoulder pain, lumbago and leg pain, rheumatism, numbness, arthralgia, muscle rigidity, swelling are that a kind of very high soft tissue of disease incidence is normal See disease, area especially more cold in winters such as northeast, Tibet, Xinjiang, patient groups more cause extensively and to patient Pain it is more lasting.Western medical treatment for because Itai-itai diseases caused by inflammation it is more effective, but for being damaged because of wound, work And the factors such as cold and the Itai-itai diseases that induce, generally the effect is relatively poor for western medical treatment, even without effect, is generally also easy multiple Hair, and doctor trained in Western medicine usually has very big side effect.Chinese medicine is more effective for the treatment of bi Zheng, especially when human body is by exopathogen Invasion so that energy and blood of human body stagnate, channels and collaterals obstruction so that dysarthrasis.
Achieve the purpose that analgesia detumescence, dispelling wind and eliminating dampness, activating microcirculation and removing stasis medicinal are that China is traditional since ancient times with Chinese medicine ointment Chinese traditional treatment method, he being capable of Zhi Genzhiben, thoroughly elimination ostalgia disease.Common ointment has rheumatism plaster, shangshi zhitong plaster, shangshi zhitong gao, this A little plaster have the effect of relatively good for different cases, but it has the shortcomings that cure mainly and has a single function, especially for Treat the lumbocrural pain of caused by hyperosteogeny not good curative effect.
Summary of the invention
In view of this, the present invention provides one kind to have the characteristics that eliminate wind and clear damp, relaxing tendons and activating collaterals, promoting blood circulation and stopping pain, solution poison rash Draft conserve cream, by way of the combination of Chinese tradiational and Western medicine, for it is existing treatment heumatism card prescription and plaster defect, passed through with ointment Percutaneous drug delivery has the characteristics that easy to use, good effect, efficacy time are long.
To achieve the above object, the invention provides the following technical scheme:
Draft conserve cream, which is characterized in that by water, white oil, stearic acid, camphor, vaseline, wintergreen, glycerin monostearate, Stearyl alcohol, glycerol, menthol, triethanolamine, Salvia root P.E, ginger oil, pallas pit viper extract, Herba speranskiae tuberculatae extract, safflower mention It takes object, extractive of pubescent angelica root coumarin, bee venom, ostrich oil, imidazolidinyl urea and chlorhexidine acetate to match according to certain component to constitute.
Preferably, it in a kind of above-mentioned draft maintenance cream, is combined according to following percentage: water 56.04%, white oil 7%, stearic Sour 6%, camphor 6%, vaseline 4.5%, wintergreen 4.5%, glycerin monostearate 3.5%, stearyl alcohol 3.5%, glycerol 1.8%, peppermint Brain 1%, triethanolamine 0.7%, Salvia root P.E 0.7%, ginger oil 0.7%, pallas pit viper extract 0.5%, Herba speranskiae tuberculatae extract 0.5%, Safflower extract 0.5%, extractive of pubescent angelica root coumarin 0.5%, Millettia extract 0.5%, bee venom 0.5%, ostrich oil 0.35%, imidazolidinyl Urea 0.4% and chlorhexidine acetate 0.31%.
Preferably, in a kind of above-mentioned draft maintenance cream, the ostrich oil is Struthionidae animal Iceland ostrich or African ostrich The fat of bird.
Preferably, in a kind of above-mentioned draft maintenance cream, the appearance of the maintenance cream is in paste, and color is white or shallow Yellow, free from admixture.
Preferably, in a kind of above-mentioned draft maintenance cream, water, Salvia root P.E, pallas pit viper are mentioned first, in accordance with aforementioned proportion It takes object, Herba speranskiae tuberculatae extract, safflower extract, extractive of pubescent angelica root coumarin to carry out mixing and forms water phase；Then with white oil, tristearin Acid, vaseline, wintergreen, glycerin monostearate, stearyl alcohol, glycerol, triethanolamine, ginger oil carry out it as oily phase Heating makes its fusing；Then water-oil phase is mixed into heat preservation emulsification, camphor, bee venom, ostrich oil, imidazolidinyl urea, acetic acid is added Chlorhexidine, by being stirred, after mixing carry out it is filling, packaging finished product is made.
It can be seen via above technical scheme that compared with prior art, the invention discloses a kind of draft to conserve cream, packet Include: water 56.04%, white oil 7%, stearic acid 6%, camphor 6%, vaseline 4.5%, wintergreen 4.5%, glycerin monostearate 3.5%, Stearyl alcohol 3.5%, glycerol 1.8%, menthol 1%, triethanolamine 0.7%, Salvia root P.E 0.7%, ginger oil 0.7%, pallas pit viper are extracted Object 0.5%, Herba speranskiae tuberculatae extract 0.5%, safflower extract 0.5%, extractive of pubescent angelica root coumarin 0.5%, Millettia extract 0.5%, bee venom 0.5%, ostrich oil 0.35%, imidazolidinyl urea 0.4% and chlorhexidine acetate 0.31%.Present invention combination doctor trained in Western medicine safety is good, imitates Fruit active material outstanding, obtains by largely testing, and there is dispelling wind and eliminating dampness, relaxing tendons and activating collaterals, promoting blood circulation and stopping pain, solution to poison rash Effect.
Specific embodiment
Below in conjunction with the embodiment of the present invention, technical scheme in the embodiment of the invention is clearly and completely described, Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Based in the present invention Embodiment, every other embodiment obtained by those of ordinary skill in the art without making creative efforts, all Belong to the scope of protection of the invention.
The embodiment of the invention discloses a kind of grass for having the characteristics that eliminate wind and clear damp, relaxing tendons and activating collaterals, promoting blood circulation and stopping pain, solution and poisoning rash This maintenance cream.
A kind of draft maintenance cream disclosed by the invention is please referred to, is specifically included:
By water, white oil, stearic acid, camphor, vaseline, wintergreen, glycerin monostearate, stearyl alcohol, glycerol, menthol, three Ethanol amine, Salvia root P.E, ginger oil, pallas pit viper extract, Herba speranskiae tuberculatae extract, safflower extract, extractive of pubescent angelica root coumarin, bee venom, Ostrich oil, imidazolidinyl urea and chlorhexidine acetate are matched according to certain component and are constituted.
In order to further optimize the above technical scheme, it is combined according to following percentage: water 56.04%, white oil 7%, stearic acid 6%, camphor 6%, vaseline 4.5%, wintergreen 4.5%, glycerin monostearate 3.5%, stearyl alcohol 3.5%, glycerol 1.8%, menthol 1%, triethanolamine 0.7%, Salvia root P.E 0.7%, ginger oil 0.7%, pallas pit viper extract 0.5%, Herba speranskiae tuberculatae extract 0.5%, red Flower extract 0.5%, extractive of pubescent angelica root coumarin 0.5%, Millettia extract 0.5%, bee venom 0.5%, ostrich oil 0.35%, imidazolidinyl urea 0.4% and chlorhexidine acetate 0.31%.
In order to further optimize the above technical scheme, ostrich oil is the rouge of Struthionidae animal Iceland ostrich or African Ostrich Fat.
In order to further optimize the above technical scheme, the appearance of cream is conserved in paste, and color is white or light yellow, nothing Impurity.
In order to further optimize the above technical scheme, water, Salvia root P.E, pallas pit viper are extracted first, in accordance with aforementioned proportion Object, Herba speranskiae tuberculatae extract, safflower extract, extractive of pubescent angelica root coumarin, which be mixed, forms water phase；Then with white oil, stearic acid, Vaseline, wintergreen, glycerin monostearate, stearyl alcohol, glycerol, triethanolamine, ginger oil heat it as oily phase Make its fusing；Then by water-oil phase mix heat preservation emulsification, be added camphor, bee venom, ostrich oil, imidazolidinyl urea, acetic acid chlorine oneself Calmly, filling, packaging is carried out by being stirred, after mixing, and finished product is made.
In order to further optimize the above technical scheme, physical and chemical index of the invention is as follows:
Project Index
PH value 6.5~8.5
Chlorhexidine acetate, % 0.29~0.32
It is heat-resisting (40 ± 1) DEG C are kept for 24 hours, and permeability worry should not exceed 3% after restoring room temperature
It is cold-resistant (- 8 ± 2) DEG C are kept for 24 hours, preceding without obvious Traits change with test after recovery room temperature
Lead (in terms of Pb), mg/kg ≤10
Female (in terms of As), mg/kg ≤2
Mercury (in terms of Hg), mg/kg ≤1
Each embodiment in this specification is described in a progressive manner, and the highlights of each of the examples are implement with other The difference of example, the same or similar parts in each embodiment may refer to each other.For the device disclosed in the embodiment, Since it is corresponded to the methods disclosed in the examples, so being described relatively simple, related place is referring to method part illustration It can.
The foregoing description of the disclosed embodiments enables those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, as defined herein General Principle can be realized in other embodiments without departing from the spirit or scope of the present invention.Therefore, of the invention It is not intended to be limited to the embodiments shown herein, and is to fit to and the principles and novel features disclosed herein phase one The widest scope of cause.

Claims (5)

1. draft conserves cream, which is characterized in that by water, white oil, stearic acid, camphor, vaseline, wintergreen, glycerol monostearate Ester, stearyl alcohol, glycerol, menthol, triethanolamine, Salvia root P.E, ginger oil, pallas pit viper extract, Herba speranskiae tuberculatae extract, safflower Extract, extractive of pubescent angelica root coumarin, bee venom, ostrich oil, imidazolidinyl urea and chlorhexidine acetate are matched according to certain component and are constituted.
2. draft according to claim 1 conserves cream, which is characterized in that combined according to following percentage: water 56.04%, white Oily 7%, stearic acid 6%, camphor 6%, vaseline 4.5%, wintergreen 4.5%, glycerin monostearate 3.5%, stearyl alcohol 3.5%, glycerol 1.8%, menthol 1%, triethanolamine 0.7%, Salvia root P.E 0.7%, ginger oil 0.7%, pallas pit viper extract 0.5%, lopseed mention Take object 0.5%, safflower extract 0.5%, extractive of pubescent angelica root coumarin 0.5%, Millettia extract 0.5%, bee venom 0.5%, ostrich oil 0.35%, Imidazolidinyl urea 0.4% and chlorhexidine acetate 0.31%.
3. draft according to claim 1 conserves cream, which is characterized in that the ostrich oil is Struthionidae animal Iceland ostrich Or the fat of African Ostrich.
4. draft according to claim 1 conserves cream, which is characterized in that the appearance of the maintenance cream is in paste, and color is It is white or light yellow, free from admixture.
5. the preparation method of draft maintenance cream according to claim 2, which is characterized in that will first, in accordance with aforementioned proportion Water, Salvia root P.E, pallas pit viper extract, Herba speranskiae tuberculatae extract, safflower extract, extractive of pubescent angelica root coumarin, which be mixed, forms water Phase；Then with white oil, stearic acid, vaseline, wintergreen, glycerin monostearate, stearyl alcohol, glycerol, triethanolamine, ginger oil As oily phase, heating is carried out to it makes its fusing；Then water-oil phase is mixed into heat preservation emulsification, camphor, bee venom, ostrich is added Oil, imidazolidinyl urea, chlorhexidine acetate, by being stirred, after mixing carry out it is filling, packaging finished product is made.
CN201810431806.4A 2018-05-08 2018-05-08 Draft conserves cream Pending CN110464821A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810431806.4A CN110464821A (en) 2018-05-08 2018-05-08 Draft conserves cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810431806.4A CN110464821A (en) 2018-05-08 2018-05-08 Draft conserves cream

Publications (1)

Publication Number Publication Date
CN110464821A true CN110464821A (en) 2019-11-19

Family

ID=68503265

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810431806.4A Pending CN110464821A (en) 2018-05-08 2018-05-08 Draft conserves cream

Country Status (1)

Country Link
CN (1) CN110464821A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112089819A (en) * 2020-10-27 2020-12-18 乐比(广州)健康产业有限公司 Massage cream for relieving muscle discomfort
CN113509538A (en) * 2021-04-27 2021-10-19 广州人为峰生物科技有限公司 A conditioning cream with optimized bee therapy effect for dredging collaterals, relieving pain, and relieving inflammation, and its preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106668818A (en) * 2017-01-25 2017-05-17 王亮 Herbal curing cream

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106668818A (en) * 2017-01-25 2017-05-17 王亮 Herbal curing cream

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
周生: "化妆品配方 ", 《日用化学品科学》 *
孙永瑞: "化妆品用原料―油脂及蜡、醇、酯、皂类 ", 《香料香精化妆品》 *
潘华: "护肤品配方 ", 《日用化学品科学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112089819A (en) * 2020-10-27 2020-12-18 乐比(广州)健康产业有限公司 Massage cream for relieving muscle discomfort
CN113509538A (en) * 2021-04-27 2021-10-19 广州人为峰生物科技有限公司 A conditioning cream with optimized bee therapy effect for dredging collaterals, relieving pain, and relieving inflammation, and its preparation method

Similar Documents

Publication Publication Date Title
US9775872B2 (en) Topical pharmaceutical bases for preventing viral diseases
CN109646379A (en) A kind of thermal sensation plant footbath liquor and preparation method thereof
JP2020504178A (en) Cosmetic composition comprising a combination of Pongamia oil and 4-t-butylcyclohexanol for treating rosacea
CN105148059A (en) Plant oil external liniment capable of repelling mosquitos and preparation method thereof
CN110464821A (en) Draft conserves cream
CN105362410B (en) Traditional Chinese medicine preparation for treating burns and scalds and preparation method
CN106806758A (en) A kind of Chinese medicine preparation for treating acne
CN105943666B (en) Composition for nursing sensitive skin of infant and preparation method thereof
CN116115707B (en) Concentrated foam medicated bath liquid for preventing and treating cow hoof rot and preparation method thereof
CN103721138B (en) A kind of traditional Chinese medicine for external application and its preparation method treating rosacea
CN103520690B (en) Foot bathing powder for relaxing muscles and joints, dredging collaterals and reducing pressure
CN104383286A (en) Paste for treating burns and scalds and preparation method of paste
KR20160020187A (en) Moxa composition and producing method thereof
CN102846799A (en) External traditional Chinese medicine paste for burn and scald treatment and preparation method thereof
CN105168610A (en) Composition for cold cough and preparation method thereof
CN105213798A (en) A kind of Chinese medicine patch for skin scar reparation and preparation method thereof
CN105456708B (en) Medicine for treating cheilitis and preparation method thereof
US9867775B2 (en) Topical pharmaceutical bases for treating inflammatory disorders
CN108066518A (en) A kind of dog Chinese medicine bath lotion composition and preparation method thereof
CN103893422B (en) Repair medicine of skin injury and preparation method thereof
CN109432240A (en) A kind of bamboo rat oil antipruritic powder poison cream and preparation method thereof
RU2238754C1 (en) Species "praskovya" and method for treatment of cutaneous disease in phyto-steaming therapy
JP6590233B1 (en) Skin disease therapeutic agent and method for producing the same
RU2355411C1 (en) Wound- healing ointment
US20160106797A1 (en) Topical treatment of shingles

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191119

RJ01 Rejection of invention patent application after publication